These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19776116)

  • 1. Bacteriophage-mediated toxin gene regulation in Clostridium difficile.
    Govind R; Vediyappan G; Rolfe RD; Dupuy B; Fralick JA
    J Virol; 2009 Dec; 83(23):12037-45. PubMed ID: 19776116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RstA Is a Major Regulator of Clostridioides difficile Toxin Production and Motility.
    Edwards AN; Anjuwon-Foster BR; McBride SM
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862746
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens.
    Sekulovic O; Meessen-Pinard M; Fortier LC
    J Bacteriol; 2011 Jun; 193(11):2726-34. PubMed ID: 21441508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.
    Merrigan M; Venugopal A; Mallozzi M; Roxas B; Viswanathan VK; Johnson S; Gerding DN; Vedantam G
    J Bacteriol; 2010 Oct; 192(19):4904-11. PubMed ID: 20675495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.
    Bakker D; Smits WK; Kuijper EJ; Corver J
    PLoS One; 2012; 7(8):e43247. PubMed ID: 22912837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-Terminal Domain of Clostridioides difficile TcdC Is Exposed on the Bacterial Cell Surface.
    Oliveira Paiva AM; de Jong L; Friggen AH; Smits WK; Corver J
    J Bacteriol; 2020 Oct; 202(22):. PubMed ID: 32868401
    [No Abstract]   [Full Text] [Related]  

  • 7. Clostridium difficile toxin synthesis is negatively regulated by TcdC.
    Dupuy B; Govind R; Antunes A; Matamouros S
    J Med Microbiol; 2008 Jun; 57(Pt 6):685-689. PubMed ID: 18480323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.
    Matamouros S; England P; Dupuy B
    Mol Microbiol; 2007 Jun; 64(5):1274-88. PubMed ID: 17542920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE.
    Govind R; Dupuy B
    PLoS Pathog; 2012; 8(6):e1002727. PubMed ID: 22685398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.
    McKee RW; Mangalea MR; Purcell EB; Borchardt EK; Tamayo R
    J Bacteriol; 2013 Nov; 195(22):5174-85. PubMed ID: 24039264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
    Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
    Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA
    Kodori M; Ghalavand Z; Yadegar A; Eslami G; Azimirad M; Krutova M; Abadi A; Zali MR
    Anaerobe; 2020 Dec; 66():102294. PubMed ID: 33181348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119.
    Revathi G; Fralick JA; Rolfe RD
    Anaerobe; 2011 Jun; 17(3):125-9. PubMed ID: 21664468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that Clostridium difficile TcdC is a membrane-associated protein.
    Govind R; Vediyappan G; Rolfe RD; Fralick JA
    J Bacteriol; 2006 May; 188(10):3716-20. PubMed ID: 16672625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the Mechanism of Lysogeny Control of phiCDKH01 Bacteriophage Infecting Clinical Isolate of
    Iwanicki A; Roskwitalska M; Frankowska N; Wultańska D; Kabała M; Pituch H; Obuchowski M; Hinc K
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891850
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR.
    El Meouche I; Peltier J; Monot M; Soutourina O; Pestel-Caron M; Dupuy B; Pons JL
    PLoS One; 2013; 8(12):e83748. PubMed ID: 24358307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spores of Clostridioides difficile are toxin delivery vehicles.
    Cassona CP; Ramalhete S; Amara K; Candela T; Kansau I; Denève-Larrazet C; Janoir-Jouveshomme C; Mota LJ; Dupuy B; Serrano M; Henriques AO
    Commun Biol; 2024 Jul; 7(1):839. PubMed ID: 38987278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
    Murray R; Boyd D; Levett PN; Mulvey MR; Alfa MJ
    BMC Infect Dis; 2009 Jun; 9():103. PubMed ID: 19558711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of Clostridium difficile toxin gene expression by CodY.
    Dineen SS; Villapakkam AC; Nordman JT; Sonenshein AL
    Mol Microbiol; 2007 Oct; 66(1):206-19. PubMed ID: 17725558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.